Pratik Shah
Algemeen Directeur bij DESIGN THERAPEUTICS, INC.
Vermogen: 51 M $ op 30-06-2024
Actieve functies van Pratik Shah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DESIGN THERAPEUTICS, INC. | Algemeen Directeur | 25-08-2023 | - |
| Voorzitter | 18-12-2017 | - | |
| Financieel Directeur/CFO | - | - | |
| Oprichter | 18-12-2017 | - | |
| President | 25-08-2023 | - | |
| ARS PHARMACEUTICALS, INC. | Voorzitter | 01-09-2018 | - |
| Directeur/Bestuurslid | 01-04-2016 | - | |
| Marlinspike Group LLC | President | 01-08-2018 | - |
UC San Diego Foundation
 UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous UC San Diego Foundation specializes in obtaining private gifts in support of research, teaching, and public service, as well as engages in management of gift assets. The company is was founded in 1972 and is headquartered in La Jolla, CA. | Directeur/Bestuurslid | - | - |
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Voorzitter | 01-09-2018 | - |
Loopbaan van Pratik Shah
Eerdere bekende functies van Pratik Shah
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SYNTHORX, INC. | Directeur/Bestuurslid | 11-10-2018 | 20-12-2018 |
| Voorzitter | 20-12-2018 | 01-02-2022 | |
| Independent Dir/Board Member | 11-10-2018 | 01-02-2022 | |
| Marlinspike Group, Inc. | Algemeen Directeur | 01-06-2015 | 01-10-2020 |
| President | 01-06-2015 | 01-10-2020 | |
| AUSPEX PHARMACEUTICALS INC | Algemeen Directeur | 01-01-2013 | 01-05-2015 |
| Voorzitter | 01-06-2007 | 01-01-2013 | |
| President | 01-01-2013 | 01-05-2015 | |
| OCERA THERAPEUTICS INC | Directeur/Bestuurslid | 01-09-2005 | 18-02-2014 |
| Independent Dir/Board Member | 01-09-2005 | 18-02-2014 | |
| ░░░░░░░ ░░░░░░░░ ░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
| ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░ | ░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van Pratik Shah
| The University of Chicago | Doctorate Degree |
| University of California, Irvine | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 19 |
Operationeel
| Director/Board Member | 7 |
| Chairman | 5 |
| President | 4 |
Sectoraal
| Health Technology | 12 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| DESIGN THERAPEUTICS, INC. | Health Technology |
| ARS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 14 |
|---|---|
Thomas, McNerney & Partners LLC
 Thomas, McNerney & Partners LLC Investment ManagersFinance Thomas, McNerney & Partners LLC (Thomas McNerney & Partner) is a venture capital subsidiary of the Coral Group Inc founded in 1998. The firm is headquartered in Minneapolis, Minnesota. | Finance |
NephRx Corp.
 NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Cebix, Inc.
 Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA. | Health Technology |
CNS Therapeutics, Inc.
 CNS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology CNS Therapeutics, Inc. develops and manufactures drug delivery products. The company was founded in 2007 and is headquartered in St. Paul, MN. | Health Technology |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Health Technology |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
Super Green Biofuels, Inc.
 Super Green Biofuels, Inc. BiotechnologyHealth Technology Super Green Biofuels, Inc. develops and markets sustainable plant oils, proteins, and biomass products as sources for industrial materials, energy, and food. Its proprietary plant genomics, breeding and agronomy platform aims to improve and domesticate existing and emerging crops. Its services include molecular breeding, hybrid seed production, HTP genotyping, and gene discovery. The company was founded by Georges J. Daou in 2007 and is headquartered in San Diego, CA. | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. | Health Technology |
| Marlinspike Group, Inc. | |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Health Technology |
UC San Diego Foundation
UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous UC San Diego Foundation specializes in obtaining private gifts in support of research, teaching, and public service, as well as engages in management of gift assets. The company is was founded in 1972 and is headquartered in La Jolla, CA. | Miscellaneous |
| Marlinspike Group LLC |
- Beurs
- Insiders
- Pratik Shah
- Ervaring
